Clinical Trials : Pediatric Ulcerative Colitis


Recruiting	: An Efficacy and Safety Study of Infliximab in Pediatric Participants With Inflammatory Bowel Disease : Inflammatory Bowel Diseases : 2015-10-01 : Drug: Infliximab Participants in the dose escalation group will escalate dose from infliximab 5 mg/kg q8
Recruiting	: Manipulating the Microbiome in IBD by Antibiotics and FMT : Exacerbation of Ulcerative Colitis Ulcerative Colitis, Active Severe Drug: AB (antibiotics)